ABSTRACT
By recognizing antigens presented on class II MHC on APCs, na€ ıve CD4 þ T cells are activated to differentiate into functionally specialized helper T cell subsets, such as Th1, Th2 and Th17, each of which secretes a distinct set of cytokines. Differentiation of CD4 þ T cells into appropriate subsets of helper T cells is crucial for optimal protection against different types of pathogens. During differentiation of CD4 þ T cells, specific transcription factors that regulate the differentiation and function of the effector T cell subsets are induced in these cells. Those transcription factors, including T-bet (T-box 21 or Tbx21) in Th1 cells, GATA3 in Th2 cells and retinoic acid receptor-related orphan receptor gamma t and alpha in Th17 cells, are regarded as "master regulators" (1) . Two closely related T-box family molecules, T-bet and Eomesodermin (Eomes), have been identified as the master regulators of CD8 þ CTLs (2) . Classically, CD4
þ T cells were recognized as helper T cells, which coordinate immune responses, whereas CD8 þ cells were classified as cytotoxic T cells, which directly kill pathogen-infected cells. However, some CD4 þ T cells are known to have cytolytic potential. Although these CD4
þ CTLs were initially thought to be possible "artifacts" generated over the course of longterm in vitro cultures (3), cumulative evidence from subsequent studies has clearly demonstrated their in vivo emergence during viral infections or anti-tumor responses, implying their importance in responses to infection and malignancy (4, 5) . In addition to their contribution to responses against non-self-antigens, CD4
þ CTLs have also been implicated in regulation of autoimmune responses (6) .
Lymphocyte-mediated cytolysis is operated mainly via two pathways: the perforin/granzyme and Fas ligand (FasL [CD178])-Fas pathways (7) . While most CD8
þ CTLs and NK cells utilize both pathways, some CD4
þ CTLs do not express perforin and kill target cells using only FasL (8, 9) . Given that cytotoxicity and IFN-g production are correlated, researchers have postulated that CTL activity among CD4 þ T cells is attributable to Th1 cells. However, it is also possible that CD4
þ CTLs may comprise a distinct, independent subset of CD4 þ effector T cells that differ from conventional Th1 cells (10) . Indeed, several recent reports have identified specific markers for CD4 þ CTLs (11) (12) (13) (14) . Interestingly, Eomes is expressed in many of the cells expressing these markers, as well as in other CD4
þ T cells with cytolytic properties (15) (16) (17) (18) ; these findings suggested that Eomes governs development of CD4 þ CTLs and that Eomes expression is a marker for CD4 þ CTLs. These observations are consistent with our previous study, in which enforced Eomes expression in non-cytotoxic Th2 cells conferred cytotoxicity on them by activating both the FasL and perforin pathways (19) . However, although T-bet has been intensively investigated for its ability to regulate IFN-g production, there is still little information on its ability to activate cytolytic pathways in CD4 þ T cells. In this study, to examine whether T-bet promotes CD4 þ T cell-mediated cytotoxicity, we transfected two murine CD4 þ helper T cell lines that lack killing activity with the Tbx21 gene. Both transfectants acquired the ability to express FasL, one being capable of FasLmediated cytolysis. In one cell line, Prf1 gene expression was induced, and the Tbx21-transfectant, but not its parental line, killed Fas À target cells. Whereas, similarly to Eomes, T-bet was able to suppress up-regulation of CD40 ligand (CD40L/CD154). This ability did not affect CD40L up-regulation on Th1 cells, suggesting that there is a compensatory mechanism for optimal CD40L expression in Th1 cells. Thus, the results of this study indicate that, in addition to Eomes-expressing CD4 þ CTLs, some conventional Th1 cells may also participate in antigen-specific cytolysis.
MATERIALS AND METHODS

Cells
Selected genes were retrovirally transfected into DO11.10, a CD4 þ murine T cell hybridoma specific for an ovalbumin peptide, and 4Rq11-2, an untransformed Th2 cell line specific for allogeneic MHC class II (I-A k ) (19) . A BALB/c-derived B cell tumor, A20.2J, expressing Fas and FcR was used as the target in a cell-mediated cytolysis assay. Tumor cells were cultured in DMEM supplemented with nonessential amino acids, 1 mM sodium pyruvate, 2 mM additional glutamine, 50 mM 2-mercaptoethanol, 100 units/mL penicillin, 100 units/mL streptomycin, 20 mM HEPES buffer (pH 7.2), and 10% FCS. The 4Rq11-2 cells were maintained by bi-weekly stimulation with 20-Gyirradiated splenocytes from C3H/HeN mice in a medium containing 20 ng/mL human IL-2.
Mice C57BL/6J, C3H/HeN and MRL-lpr/lpr mice were purchased from Charles River Laboratories Japan (Kanagawa, Japan). MRL-lpr/lpr mice were crossed once onto a C3H/HeN background to dilute the background genes of the MRL strain and thus reduce disease severity. All mice used in this study were maintained in a specific-pathogen-free facility at the Kitasato University School of Medicine. The Animal Experimentation and Ethics Committee of the Kitasato University School of Medicine approved the experimental procedures and all animal experiments were performed according to the committee's guidelines.
Antibodies and reagents
Biotinylated antibodies to CD40L and FasL, PE-labeled antibodies to T-bet and Eomes and an APC-labeled antiCD8a antibody were purchased from BioLegend (San Diego, CA, USA). FITC-labeled anti-CD4 antibody and PE-labeled streptavidin were obtained from BD Biosciences (San Jose, CA, USA). Antibodies to CD3 (2C11), IL-4 (11B11), IFN-g (XMG1.2) and FcgR II/III (2.4G2) were prepared from hybridomas in the laboratory. ConA, PMA and the calcium ionophore ionomycin were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Retroviral transfection
A bicistronic retroviral vector, MigR1, containing a GFP gene ligated downstream of an internal ribosomal entry site (19) was used for transfection of the Eomes, Tbx21 and Prf1 genes. Viral particles were produced by transfecting retroviral vector constructs into Phoenix-ECO packaging cells using Lipofectamine (Invitrogen, Carlsbad, CA, USA). Virus-containing supernatant supplemented with 8 mg/mL polybrene (Sigma-Aldrich) was added to the cultured DO11.10 or pre-activated 4Rq11-2 cells. The plates were then centrifuged at 4000 rpm for 90 min at 16°C to facilitate infection.
Development of Th1 and Th2 cells from C57BL/6 mice
CD44
loþ CD4 þ T cells were sorted from the spleens of C57BL/6 mice with FACSAria (BD Biosciences), then stimulated with 1 mg/mL anti-CD3 antibody and irradiated C57BL/6 splenocytes in the presence of 10 ng/mL IL-12 (BioLegend) and 10 mg/mL anti-IL-4 antibody for Th1 differentiation, or in the presence of 10 ng/mL IL-4 (BioLegend) and 10 mg/mL anti-IFN-g antibody for Th2 differentiation, for 5 days. Thereafter, the cells were cultured in a medium containing 50 ng/mL human IL-2 for 7 days, after which they were stimulated with PMA and ionomycin to determine their cytokine production profiles.
Flow cytometric analyses
For flow cytometric analyses, 2-10 Â 10 5 cells were stained in 2.4G2 culture supernatants containing predetermined concentrations of fluorescently labeled antibodies for 30 min on ice. Cells were then washed with ice-cold PBS containing 0.5% BSA and 0.02% sodium azide. Intracellular staining was performed using a BD Cytofix/Cytoperm kit (BD Biosciences). The stained cells were analyzed on a FACSCalibur or FACSVerse (BD Biosciences) and the resultant data processed using CellQuest or FlowJo software.
Cell-mediated lysis assay
Cell-mediated lysis assays were performed as described previously (19) . Briefly, 5-10 Â 10 3 51 Cr-labeled target cells/well were mixed with a graded number of effector T cells in a round-bottomed microtiter plate. After a 6-hour incubation, the supernatants were harvested and the radioactivity in the supernatants measured with a gamma counter. Specific lysis We calculated as follows:
where ER is the experimental release, SR the spontaneous release and MR the maximal release. Spontaneous release and maximum release were determined in wells with target cells alone and wells in which target cells were lysed with 0.5% NP-40, respectively. The assays were performed in triplicate. In some experiments, cytolytic activity was measured with a re-directed assay using the FcR þ murine B cell lymphoma, A20.2J, as the target in the presence of 1 mg/mL anti-CD3 antibody. To prepare "LPS-blasts" as target cells, splenocytes from C3H or lpr/lpr mice were stimulated with 10 mg/mL of LPS for two days in complete DMEM with 10% FCS.
Quantitation of mRNA by PCR
Total RNA was extracted from cultured cells with TRIzol reagent (Life Technologies, Carlsbad, CA, USA). Five hundred nanogram of total RNA was subjected to reverse transcription to synthesize single-strand DNA with PrimeScript RT Master Mix (TaKaRa, Shiga, Japan) and an aliquot of single-strand DNA used as a template in PCR to quantify the mRNA of perforin, granzyme, or T-bet. Quantitative PCR was performed with SYBR Premix Ex Taq (TaKaRa) using a Bio-Rad real-time PCR system, CFX96/384 (Bio-Rad, Hercules, CA, USA). The mRNA amount of each molecule was normalized with that of Hprt. The sequences of the primers used were as follows:
RESULTS
Cytotoxicity of in vitro-differentiated murine Th1 cells expressing T-bet
Given that previous reports have suggested that many CD4 þ CTLs are capable of secreting IFN-g, we developed Th1 and Th2 cells in vitro from na€ ıve C57BL/6 CD4 þ T cells to compare their cytolytic activity. Upon activation with PMA and ionomycin, the Th1 cells produced IFN-g without expressing IL-4, whereas the Th2 cells produced only IL-4, and not IFN-g (Fig. 1a) . T-bet was expressed in virtually all Th1 cells, whereas Eomes was expressed in only a small proportion of Th1 cells (Fig. 1b) . We did not detect either T-bet or Eomes in Th2 cells. Prf1 mRNA was also expressed more abundantly in Th1 than Th2 cells (data not shown). Consistent with previous results (20), we observed cytotoxicity only by Th1 cells, but not by Th2 cells, indicating that T-bet in Th1 cells may be involved in cytolytic activity (Fig. 1c) .
Induction of FasL expression in a helper T cell line, DO11.10, transfected with T-bet
Although cytolysis by some CD4 þ T cells has been shown to be mediated preferentially via the FasL pathway, the relevance of T-bet in FasL expression remains elusive. To investigate the effect of enforced expression of T-bet on FasL expression, we transfected the Tbx21 gene into the murine helper T cell hybridoma, DO11.10. T-bet introduction did not induce appreciable amounts of Eomes in this cell line (Fig. 2a) . In Tbx21 transfectant, expression of neither Pfr1 nor Gzmb mRNA was elicited (Fig. 2b) , as was the case with Eomestransfected DO11. 10 (19) .
After stimulation with ConA for 2 hrs, we examined the cells for FasL expression. We included an Eomes-transfectant that is capable of expressing FasL (19) as a positive control. As shown in Fig. 3a , FasL expression was induced in both Tbx21 and Eomes transfected cells but scarcely in control cells transfected with the empty vector. The induced FasL expression appeared functional: we observed cytotoxicity by the Tbx21-transfectant, but not the control cells, on Fas þ target cells (Fig. 3b) . Given that we detected only minimal expression of Prf1 or Gzmb gene in the Tbx21-transfectant (Fig. 2b) , the cytolysis mediated by the Tbx21-transfectant is likely to be FasL pathway- 
Enforced expression of T-bet may confer cytotoxicity in a murine untransformed Th2 cell line by activating the perforin pathway
To investigate whether T-bet's ability to confer cytotoxicity on the CD4 þ hybridoma is also applicable to other CD4 þ T cells, we introduced the Tbx21 gene into 4Rq11-2, an untransformed Th2 cell line that recognizes murine MHC class II (I-A k ) as an alloantigen (Fig. 4a ). Although they expressed granzyme B, as Th2 cells frequently do (21), 4Rq11-2 cells lacked cytotoxicity, probably because of the very weak perforin expression and absence of FasL expression (19) . However, when we introduced T-bet into 4Rq11-2 cells, stimulation by PMA and ionomycin induced substantial FasL expression on the cell surface (Fig. 4b) .
While T-bet expression in DO11.10 cells did not elicit Prf1 gene activation, Prf1 mRNA expression was significantly increased in 4Rq11-2 cells transfected with T-bet (Fig. 5a ). To determine whether up-regulation of perforin gene expression confers FasL-independent cytotoxicity, we assessed the cytolytic activity of T-bet-expressing 4Rq11-2 cells against Fas-mutated target cells from lpr/lpr mice. As shown in Fig 5b, T-bet-transfected 4Rq11-2 cells lysed lpr/lpr target cells that were deficient for the Fas antigen. Although Prf1 transfectant more strongly expresses Prf1 mRNA than does Eomes transfectant (19) or Tbx21 transfectant, cytolytic activity was always greater in Eomes-or Tbx21 transfectant, suggesting that T-bet as well as Eomes may play important role(s) in facilitating the function of perforin and granzyme B (19) . These results collectively indicate that, similarly to Eomes, T-bet can convert noncytocidal CD4 þ T cells into cytotoxic cells by activating both FasL-and perforin-dependent cytolytic pathways.
Suppressive effect of T-bet on CD40L up-regulation
In our previous study, we demonstrated that ectopic expression of Eomes in Th2 cells represses up-regulation of CD40L, a key effector molecule that is commonly observed in various CD4 þ helper T cell subsets, including Th1 cells (22) . Eomes was therefore thought to be at least partially responsible for suppression of CD40L expression on CD8 þ T cells. However, given that T-bet is more prevalently expressed in CD4 þ T cells than is Eomes, it is possible that T-bet does not suppress CD40L. We therefore examined the effect of T-bet expression on expression of CD40L in 4Rq11-2 cells, using Prf1 transfectant as a control. In the absence of activation, CD40L was not expressed on either transfectant (data not shown). However, stimulation with PMA and ionomycin induced cell surface expression of CD40L (Fig. 6a) . In Prf1-transfected cells, the proportion of CD40L þ cells was similar in GFP þ (perforin-positive) and untransfected GFP À cells. In contrast, in the T-bet-transfectants, the percentage of CD40L þ cells was significantly lower among the GFP þ cells than the GFP À cells, similar to the results for the Eomes transfectant. These results imply that T-bet, as well as Eomes, inhibits CD40L up-regulation.
To investigate whether this activity of T-bet applies to Th1 cells, we stimulated freshly prepared bulk C57BL/6 Th1 and Th2 cells with PMA and ionomycin and examined their expression of CD40L. As shown in Fig. 6b , the expression of CD40L was similar on Th1 and Th2 cells, indicating that T-bet-mediated repression of 
DISCUSSION
The two T-box family molecules, T-bet and Eomes, have multiple roles in elaborating the effector functions of CD4 þ and CD8 þ T cells (23) . Despite the fact that these molecules are often found in cytotoxic cells, and that many cytotoxic cells express FasL, the relevance of T-box molecules in FasL expression had not yet been determined. In a prior study, we demonstrated that Eomes activates not only the perforin-mediated cytolytic pathway, but also the FasL pathway, thus conferring cytotoxicity on non-cytocidal T cells (19) . In the current study, we extended those observations and found that T-bet may also have a similar activity.
Whereas T-bet and Eomes belong to the same subfamily within the T-box family and share some functions, such as promoting IFN-g secretion or perforin/ granzyme B gene expression in CD8
þ CTLs, they also exhibit different, and sometimes opposite, functions. For instance, Eomes supports differentiation of CD8 þ T cells into memory cells, whereas T-bet appears important for CD8 þ effector T cell differentiation (24, 25) . Eomes may also participate in up-regulation of some "exhaustion" markers, such as PD-1 in CD8
þ CTLs, whereas T-bet inhibits their expression (26) (27) (28) . Thus, it is possible that T-bet and Eomes have differential effects on expression of cytolytic effector molecules, reflecting differences in the cytolytic mechanisms between CD8 þ and CD4 þ CTLs. However, with regard to regulation of perforin, FasL, and CD40L expression, we found that T-bet may function similarly to Eomes; however, it is not yet clear whether or not T-bet is the only molecule responsible for cytolytic activity in CD4 þ T cells in the absence of Eomes. The results of the present study raise the possibility that some regulatory mechanism(s) may prevent T-bet from inducing expression of cytolytic effector molecules in non-cytotoxic Th1 cells expressing T-bet. As shown in Fig. 2b and our previous report (19) , introduction of the Tbx21 or Eomes gene into the CD4 þ murine hybridoma DO11.10 does not induce Prf1 gene expression, suggesting that expression of these T-box molecules may not be sufficient for Prf1 gene expression. This may reflect the finding that FasL expression is preserved in some Th1 clones that lack Prf1 expression (8, 9) . It is also possible that there are some regulatory mechanism(s) for preventing T-bet from inducing FasL in certain Th1 cells that are not cytotoxic. To investigate the mechanisms in more detail, simultaneous staining of T-box molecules and cytotoxic effector molecules in Th1 cells may be necessary.
T-bet introduction into an untransformed Th2 cell line, 4Rq11-2, elicited both FasL and perforin expression. Upon activation of the cells, we observed FasL up-regulation on Tbx21 transfectant but not on vectortransfected control cells, although the functionality of FasL induced on the surface of Tbx21 transfectant has remained to be assessed. Tbx21 transfection notably increased expression of Prf1 mRNA in 4Rq11-2 and this newly induced perforin is likely functional given that Tbx21 transfectants exerted efficient cytolytic activity on Fas-deficient cells from lpr/lpr mice, whereas the parental cell lack cytotoxicity, even on Fas-expressing target cells (19) . Intriguingly, Tbx21-transfectants were always more strongly cytolytic than perforin-transfected cells despite there being significantly less Prf1 mRNA in Tbx21 transfectants than Prf1 transfectants. This may imply that, in driving perforin/granzyme pathways, T-bet plays key roles other than inducing Prf1 or Gzmb mRNA and that this function of T-bet is shared with Eomes (19) .
Cytokine secretion is often considered the main effector function of helper T cells; however, CD4 þ T cells also play important roles by expressing membranebound TNF family molecules. These molecules interact with their receptors on APCs to activate or regulate the functions of various APCs (29) . Among the TNF family molecules expressed on CD4 þ T cells, CD40L and FasL are mandatory for mounting and maintaining appropriate immune responses. CD40L and FasL have some characteristics in common: both genes are located on the X chromosome and they are not normally expressed on na€ ıve or resting T cells, whereas they are transiently expressed on the cell surface shortly after antigenic stimulation. Although the molecular basis for regulation of CD40L and FasL expression is not fully understood, our previous and present studies suggest that T-bet and Eomes both enhance FasL expression and suppress upregulation of CD40L. It was surprising to us that T-bet has the ability to suppress CD40L expression, given that CD40L is required for some crucial Th1 cell functions, such as activation of macrophages (30) . However, we did not observe an obvious deficiency in CD40L expression in T-bet-expressing Th1 cells, which indicates there is a compensatory mechanism in Th1 cells for overcoming the repressive effect of T-bet on up-regulation of CD40L.
Given that most CD4 þ T cells recognize antigens bound to MHC class II molecules, CD4 þ CTLs critically contribute to eradication of viruses or tumors (4, 5) . CD4
þ CTLs have also been implicated in the pathogenesis of several autoimmune diseases, including rheumatoid arthritis and IgG4-related diseases (33, 34) . Despite the increasing recognition of CD4 þ CTLs in various aspects of immune responses, their characteristics are yet to be thoroughly addressed. Although many CD4
þ CTLs have been reported to express Eomes, our study suggests that CD4 þ CTLs may not be limited to Eomes-expressing cells and that a subset of conventional Th1 cells expressing T-bet, but not Eomes, could also be CTLs. Needless to add, the results of this study do not exclude the possibility that na€ ıve CD4 þ T cells differentiate into a specialized subset of CD4
þ CTLs, the development of which is regulated by Eomes or other transcription factors. Our results may indicate that, prior to or in the absence of Eomes expression, T-bet þ Th1 cells can display cytotoxic characteristics. Eomes tends to be expressed in CD4 þ T cells in the later stages of immune responses (10, 35) ; thus, T-bet could be responsible for cytotoxic CD4 þ T cells in the early phases of responses, such as acute viral infections (36) (37) (38) or allograft rejections (39) . Further studies are required to clarify possible differences in the mechanisms of cytolysis employed by different subsets of CTLs.
